Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 14Temozolomide 11Vincristine 9Magnetic Resonance Spectroscopy 9Cisplatin 9Etoposide 8Specimen Handling 7Radiotherapy 7X-Rays 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Lomustine 5Carboplatin 5Methotrexate 4Irinotecan 4Biopsy 4etoposide phosphate 3Thiotepa 3Radiation 3Platinum 3Nivolumab 3Filgrastim 3Celecoxib 3Bevacizumab 3Automobiles 31,2-diaminocyclohexaneplatinum II citrate 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Maintenance Chemotherapy × 1 year × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡